M

Metagenomi

180 employees

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Artificial Intelligence
Therapeutics
Machine Learning

Date founded

2018

Funding rounds raised

Total raised

$175M

from 25 investors over 25 rounds

M

Metagenomi raised $100M on January 5, 2023

Investors: Novo Holdings, Leaps by Bayer, Moderna and Catalio Capital Management

M

Metagenomi raised $80M on November 14, 2022

Investors: Ionis Pharmaceuticals, Inc.

M

Metagenomi raised $175M on January 25, 2022

Investors: Partner Fund Management, Pura Vida Investments, Millennium Partners, Surveyor Capital, YAYA Capital, Novo Holdings, Leaps by Bayer, Moderna, Marshall Wace and RA Capital Management, L.P.

M

Metagenomi raised $75M on November 12, 2020

Investors: Humboldt Fund, Leaps by Bayer, HOF Capital, Sozo Ventures, RA Capital Management, L.P. and Agent Capital

M

Metagenomi raised $26M on August 16, 2019

Investors: Humboldt Fund, HOF Capital, Agent Capital and Sozo Ventures

FAQ